Regenxbio Capital Lease Obligations from 2010 to 2024
| RGNX Stock | USD 10.01 0.46 4.82% |
Capital Lease Obligations | First Reported 2019-03-31 | Previous Quarter 85.5 M | Current Value 84.1 M | Quarterly Volatility 35 M |
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
Regenxbio | Capital Lease Obligations |
Latest Regenxbio's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Regenxbio over the last few years. Regenxbio capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Regenxbio asset purchases. For example, Regenxbio can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Regenxbio control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Regenxbio's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Regenxbio Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 31,567,258 | |
| Geometric Mean | 14,693,724 | |
| Coefficient Of Variation | 118.56 | |
| Mean Deviation | 33,558,877 | |
| Median | 5,854,000 | |
| Standard Deviation | 37,426,200 | |
| Sample Variance | 1400.7T | |
| Range | 88.9M | |
| R-Value | 0.81 | |
| Mean Square Error | 515T | |
| R-Squared | 0.66 | |
| Significance | 0.0002 | |
| Slope | 6,791,729 | |
| Total Sum of Squares | 19610.1T |
Regenxbio Capital Lease Obligations History
About Regenxbio Financial Statements
Regenxbio investors use historical fundamental indicators, such as Regenxbio's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 89.3 M | 66.1 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Regenxbio Stock Analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.